Evaluates enhanced 2-PE production and tolerance in hybrid yeast strains, suggesting a new platform for industrial applications.
2‑Phenylethanol (2‑PE) is a valuable aromatic alcohol widely used in the cosmetic, food, and pharmaceutical industries, yet its cytotoxicity remains a major bottleneck for microbial production. In this study, we evaluated a set of previously constructed triple hybrid yeast strains (H1-H5), derived from S. cerevisiae 10‑170 and the double hybrid II/6, to assess their potential for enhanced 2‑PE biosynthesis and tolerance. Comprehensive phenotypic analysis revealed that the triple hybrids consistently outperformed both parental strains, reaching 2-PE titers of up to 3 g/L within 72 h across different cultivation media. Depending on the parental strain used for comparison and the medium composition, the hybrids showed even up to 9-fold higher 2-PE production. Increase in production was observed under all tested cultivation conditions, indicating a robust and reproducible phenotype. In addition, the hybrids displayed increased tolerance to externally supplied 2-PE; for example, strain H1 retained 61% of its growth relative to untreated controls in the presence of 4 g/L 2-PE. The hybrids effectively combined advantageous traits from both parents, inheriting high production capacity from II/6 and strong tolerance from S. cerevisiae 10‑170, in some cases exceeding both. These findings highlight multi‑parental hybridisation as a scalable, non‑GMO strategy for developing robust yeast cell factories for industrial 2‑PE production and broader biotechnological applications.
No takes yet. Share an insight, caveat, or question.
Drężek et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: